Thinking of joining a study?

Register your interest

NCT05127681 | Terminated | Severe Hemophilia A


Bone Microarchitecture in Men With Hemophilia
Sponsor:

Civil Hospices of Lyon

Brief Summary:

Hemophilia A and B are hereditary sex-linked deficiencies of coagulation factors VIII and IX characterized by bleeding. Their modern therapy increases life expectancy and risk of age-related diseases, e.g., osteoporosis. Hemophilia-specific risk factors impair formation of peak bone mass and accelerate bone loss. Fractures are more frequent in hemophilic men vs. age-matched men and induce bleeding which is aggravated by manipulations and surgical intervention. The hypothesis of this study is that hemophilic men have poor bone microarchitecture (assessed by High-resolution peripheral quantitative computed tomography (HR-pQCT)) related to an imbalance between bone formation and resorption (assessed by bone turnover markers (BTM) and bone biomarkers). The study aims to assess the difference in low trabecular number (Tb.N) at the distal radius between hemophilic men (cases) and age- height-weight-ethnicity and smoking-matched healthy men (controls). Correlation between BTM and Tb.N will be also studied. Biologic markers of bone remodeling (C-terminal telopeptide of type I collagen (PINP), N-terminal propeptide of type I procollagen (CTX-I), periostin) will be studied.

Condition or disease

Severe Hemophilia A

Osteoporosis

Intervention/treatment

HR-pQCT

Blood sample

Dual energy X-ray absorptiometry

medical data collection

Phase

Not Applicable

Study Type : Interventional
Estimated Enrollment : 10 participants
Masking : None (Open Label)
Primary Purpose : Diagnostic
Official Title : Bone Microarchitecture in Men With Hemophilia
Actual Study Start Date : August 1, 2023
Estimated Primary Completion Date : February 6, 2024
Estimated Study Completion Date : February 6, 2024
Arm Intervention/treatment

Experimental: severe hemophilia A or B patients

30 patients with severe hemophilia A or B (Factor (F)VIII or Factor IX (FIX)≤ 1%) aged 20 to 60 years will be included in this study.

Radiation: HR-pQCT

Biological: Blood sample

Other: healthy men

Data of healthy men, matching in age- height-weight-ethnicity and smoking-matched with patient will be collected. These data are already available at the "Institut national de la santé et de la recherche médicale" (INSERM) research unit associated.

Radiation: Dual energy X-ray absorptiometry

Other: medical data collection

Ages Eligible for Study: 20 Years to 60 Years
Sexes Eligible for Study: Male
Accepts Healthy Volunteers: No
Criteria
Inclusion Criteria
  • Patients
    • Men aged 20 to 60 years
    • Severe hemophilia A or B (FVIII or FIX<1%)
    • Regular followed up in Lyon Hemophilia Center
    • Ability to give free and informed consent
    • Person capable of actively participating in radiological examinations
    • Healthy Mens
      • Aged 20 to 60 years
      Exclusion Criteria
      • Women
      • Not covered by health system
      • Vulnerable (adults unable to consent, protected under guardianship, prisoner)
      • Any blood coagulation abnormality other than severe hemophilia A or B
      • Having one of the following treatments against osteoporosis of more than 6 months : bisphosphonates, denosumab, teriparatide
      • With a chronical disease having a high impact on bone structure and no related to hemophilia disease, such as Cushing or Crohn diseases.

Bone Microarchitecture in Men With Hemophilia

Location Details


Please Choose a site



Bone Microarchitecture in Men With Hemophilia

How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


Not yet recruiting

France,

Cardiovascular and Pneumological Hospital

Bron, France, 69677

Loading...